Suchergebnisse - "Collett, Corinne"

PubPharm (13)

1

Listening to Women : Experiences of Using Closed-Loop in Type 1 Diabetes Pregnancy

enthalten in: Diabetes technology & therapeutics | 2023

von Lawton, J. | Kimbell, B. | Closs, M. | +9

2

Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes

enthalten in: The New England journal of medicine | 2023

von Lee, T. | Collett, C. | Bergford, S. | +64

CommentIn: N Engl J Med. 2024 Jan 11;390(2):183. - PMID 38197822

3

Rollout of Closed-Loop Technology to Pregnant Women with Type 1 Diabetes : Healthcare Professionals' Views About Potential Challenges and Solutions

enthalten in: Diabetes technology & therapeutics | 2023

von Rankin, D. | Hart, R. | Kimbell, B. | +18

4

AiDAPT : automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol

enthalten in: BMC pregnancy and childbirth | 2022

von Lee, T. | Collett, C. | Man, M. | +68

5

AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial – study protocol

enthalten in: BMC pregnancy and childbirth | 2022

von Lee, T. | Collett, C. | Man, M. | +22

6

Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial

enthalten in: Haematologica | 2021

von Jackson, G. | Davies, F. | Pawlyn, C. | +21

7

Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma : results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial

enthalten in: British journal of haematology | 2021

von Jackson, G. | Pawlyn, C. | Cairns, D. | +21

8

Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+) : Interim analysis of an open-label randomised controlled trial

enthalten in: PLoS medicine | 2021

von Jackson, G. | Pawlyn, C. | Cairns, D. | +21

9

Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma : results from Myeloma XI, a multicentre, open‐label, randomised, Phase III trial

enthalten in: British Journal of Haematology | 2021

von Jackson, G. | Pawlyn, C. | Cairns, D. | +20

10

Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI) : a multicentre, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2019

von Jackson, G. | Davies, F. | Pawlyn, C. | +20